By Heather Boerner
San Francisco Supervisor David Campos announced Thursday that he would introduce a supplemental budget request at the Board of Supervisors meeting Tuesday for $807,000 to help bring a treatment to prevent HIV infection to those who could benefit from it. The treatment, pre-exposure prophylaxis or PrEP, consists of taking Truvada, an antiretroviral drug, every day. If the request is approved, San Francisco will follow the state of Washington in providing drug assistance for PrEP.
The goal is to dramatically reduce the number of new HIV infections. Dr. Robert Grant, a professor at UCSF’s Gladstone Institute and a lead researcher in determining the efficacy of Truvada in preventing HIV infection, said at a hearing at City Hall Thursday that informal estimates suggest that if just 6,000 San Franciscans at high risk for HIV infection were to take Truvada, the number of new infections in the city might drop from about 400 a year to 50..
Today, fewer than 1,000 San Franciscans are taking Truvada for HIV prevention. Continue reading